ANIP 最新季度財報
公佈日期11/5/2026
實際每股收益(美元)1.54
實際營收(美元)290.78M
本頁面提供詳細的 ANI Pharmaceuticals Inc 財報數據,包括最新財報、下一次財報發佈日期、歷史數據,以及 ANI Pharmaceuticals Inc 財報法說會相關新聞。
| 發布日期 | 報告期末 | 每股收益/預測值 | 營收/預測值 | 每股收益超出預期幅度% | 營收超出預期幅度% |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | 1.54/2.18 | 290.78M/280.20M | -29.28% | 3.78% |
| 8/7/2026 | 06/2026 | 1.09/2.05 | 266.04M/260.13M | -46.98% | 2.27% |
| 5/8/2026 | 03/2026 | 1.31/1.30 | 237.46M/207.57M | 0.52% | 14.40% |
| 2/27/2026 | 12/2025 | 1.23/2.00 | 247.06M/231.53M | -38.51% | 6.71% |
| 11/7/2025 | 09/2025 | 1.19/1.75 | 227.81M/211.04M | -32.42% | 7.95% |
| 8/8/2025 | 06/2025 | 0.37/1.42 | 211.37M/190.29M | -74.00% | 11.08% |
| 5/9/2025 | 03/2025 | 0.70/1.38 | 197.12M/180.68M | -49.42% | 9.10% |
| 2/28/2025 | 12/2024 | -0.55/1.44 | 190.57M/175.37M | -138.28% | 8.67% |
ANI製藥 (ANIP) 2026年第三季電話財報會議:Cortrophin 財測下修,EBITDA 展望調升